Nature Communications (Aug 2020)

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

  • Lang Wu,
  • Yaohua Yang,
  • Xingyi Guo,
  • Xiao-Ou Shu,
  • Qiuyin Cai,
  • Xiang Shu,
  • Bingshan Li,
  • Ran Tao,
  • Chong Wu,
  • Jason B. Nikas,
  • Yanfa Sun,
  • Jingjing Zhu,
  • Monique J. Roobol,
  • Graham G. Giles,
  • Hermann Brenner,
  • Esther M. John,
  • Judith Clements,
  • Eli Marie Grindedal,
  • Jong Y. Park,
  • Janet L. Stanford,
  • Zsofia Kote-Jarai,
  • Christopher A. Haiman,
  • Rosalind A. Eeles,
  • Wei Zheng,
  • Jirong Long,
  • The PRACTICAL consortium,
  • CRUK Consortium,
  • BPC3 Consortium,
  • CAPS Consortium,
  • PEGASUS Consortium

DOI
https://doi.org/10.1038/s41467-020-17673-9
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

Genome wide association studies have identified multiple loci associated with risk of developing prostate cancer but the functional significance of many of these are unknown. Here, after generating models to predict methylation, the authors identify CpG methylation sites associated with prostate cancer.